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Abstract
Porcine parvovirus (PPV) is the major causative agent in a syndrome of reproductive failure in swine. Much has been 
learned about the structure and function of PPV in recent years, but nothing is known about the epitopes of the 
structural protein VP1, which is an important antigen of PPV. In this study, the monoclonal antibody C4 against VP1 of 
PPV was prepared and was used to biopan a 12-mer phage peptide library three times. The selected phage clones 
were identified by ELISA and then sequencing. The amino acid sequences detected by phage display were analyzed, 
and a mimic immuno-dominant epitope was identified. The epitope of VP1 is located in the N-terminal and contains 
the role amino acid sequence R-K-R. Immunization of mice indicated that the phage-displayed peptide induces 
antibodies against PPV. This study shows that peptide mimotopes have potential as alternatives to the complex 
antigens currently used for diagnosis of PPV infection or for development of vaccines.
Introduction
Porcine parvovirus (PPV), which was first isolated from
sows in Germany by Mayr et al. [1] and which belongs to
the genus Parvovirus in the family Parvoviridae, is the
major causative virus in a syndrome of reproductive fail-
ure in swine. This syndrome is referred to as SEDI and
includes stillbirths, mummified fetuses, early embryonic
death, and infertility [2]. Recent studies indicate that, in
addition to inducing reproductive failure, PPV also
causes dermatitis, diarrhea, and respiratory system dis-
ease [3-10].
PPV is composed of structural protein and non-struc-
tural protein, and the structural protein is the virus's
main immunological antigen. Using SDS-PAGE, Moliter
et al. [11] identified three kinds of structural proteins:
VP1, VP2, and VP3. All three of these proteins can induce
hemagglutination inhibition (HI) antibodies and neutral-
ization antibodies in rabbits; induction of HI antibodies
was greatest with VP3, intermediate with VP2, and least
with VP1.
VP1 has an important biological function for PPV: its
intranuclear signal sequence, which is similar to that of
the VP1 proteins of Simian virus 40 and human papillo-
mavirus [12], is very important for PPV positioning
within the host nucleus. The N-terminal of VP1 is rich in
alkaline amino acids, which enhance binding with host
DNA to stabilize viral single-strand genome DNA; the
binding is required for the initiation of viral DNA repro-
duction and for the packaging of the viral genome [13].
The structural proteins of a related virus, canine parvo-
virus (CPV), have three antigen epitope regions In the
case of CPV, the epitope located in region B1 possesses
good antigenicity and induces the host to produce neu-
tralization antibody [14,15]. Unfortunately, such informa-
tion about antigen epitope is unavailable for PPV.
Phage display is a powerful tool for the study of the
interaction between antigen and antibody. This molecu-
lar biology technique can directly select simulated anti-
gen epitopes that can combine to antibody in random
protein banks. Before phage display can be used, the
sequence of amino acids in the epitope must be deter-
mined [16]. Using monoclonal antibodies, we selected
one peptide that mimics the VP1 epitope of PPV from a
phage-displayed random peptide library. To assess its
diagnostic value, we screened a panel of 12 individual
PPV sera for their reactivity with the peptides alone. The
information obtained from this screening was used to
further analyze the structure and function of VP1. The
epitope information obtained in this study will be used to
establish serodiagnostics for PPV infection and possibly
to develop a vaccine.
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Virus and cells
PPV BQ strain was a field isolate identified by sequenc-
ing, and its complete genome sequence was submitted to
GenBank with accession no. EU790641[17]. SP2/0 cells
were kept in the Harbin Veterinary Institute (HVRI) of
Chinese Academy of Agricultural Sciences.
Preparation and purification of monoclonal antibodies 
(mAbs)
BALB/c female mice, obtained from the Experimental
Animal Center of HVRI, were intraperitoneally immu-
nized with 100 mg/ml of PPV, which was purified, dis-
solved in PBS, and mixed with MONTANIDETM IMS
1312 adjuvant (virus in PBS:adjuvant at 1:1). The adjuvant
solution was kindly provided by the SEPPIC Company.
Mice were later inoculated every 2 weeks for four times
total. Seven days after the last booster inoculation,
peripheral blood was collected from the tail vein of each
mouse and was analyzed by indirect ELISA as described
in Sulkanen et al. [18]. The mouse with the highest titre of
anti-PPV antibodies was chosen for the fusion protocol.
mAbs were derived by somatic cell hybridization of SP2/0
myeloma cells to spleen cells from the selected mouse as
described by Kohler and Milstein [19] with minor modifi-
cations. Cell culture supernatants were screened by indi-
rect ELISA using plates coated with activated PPV.
Positive cell cultures were expanded and cloned by limit
dilution. After three rounds of selection, 15 mAbs were
generated following conventional protocols. The 15
mAbs did not react to Porcine Circovirus, Porcine Pseu-
dorabies Virus, or Porcine Reproductive or Respiratory
Syndrome Virus (data not shown). The 15 mAbs belong
to the IgG1 subclass, and they have κ type light chains.
The ascites titres of these mAbs were determined.
Western blotting assay
Western blot was performed according to standard pro-
cedure. Purified protein samples (the recombinant pET-
VP1) were separated by SDS-PAGE with 12% gel prior to
electrophoretic transfer to a nitrocellulose membrane.
Western transfer was carried out in cold transferring buf-
fer (0.025 M Tris-0.19 M glycine, 20% methanoland).
Nitrocellulose membrane was then blocked overnight at
4°C with 10% skimmed milk in TBST (Tris-buffered
saline with 0.1% Tween 20, pH 8.0). After washing with
TBST, the membrane was incubated for 60 min with
mAbs at 4°C. The membrane was washed and incubated
for 60 min with horseradish peroxidase-conjugated rabbit
anti-pig antibody. After further washing, immunoreactive
proteins were visualized using DAB.
IFA The IFA was carried out using fixed 96-well cell cul-
ture plate, the mAbs were diluted 1:20 in PBS (pH7.2). 96-
well cell culture plate were equilibrated to room tempera-
ture and 50 μl of the diluted mAbs was placed in one well;
each slide was incubated with a positive and a negative
control serum diluted 1:20. The slides were incubated in a
humidified chamber at 37°C for 30 min, flushed with
PBS, then soaked for 10 min in PBS and blotted. Fifty
microliter of a 1:200 dilution of fluoresce in isothiocya-
nate-labeled goat anti-mice IgG was added to each well
and the slides were incubated at 37°C for 30 min and then
washed as before. The slides were dried and a coverslip
mounted with one drop of mounting fluid. Slides were
examined for fluorescence immediately using a Zeiss flu-
orescent microscope at 400.
One of the mAbs, designated C4, was specific against
VP1 of PPV (see Results). Ascites of C4 mAb were col-
lected and purified by standard protein G column chro-
matography (Sigma) following the manufacturer's
instructions.
Library construction
The Ph.D.-12 phage display peptide library kit (New Eng-
land Biolabs, Beverly, MA, USA) was used to screen for
specific peptide binding to VP1 of PPV. The phage display
library kit consists of a combinatorial library of random
peptide 12-mers fused to a minor coat protein (pIII) of
the M13 phage. The titer of the library is 1.5 × 1013 pfu
(plaque-forming units). The library contains a complexity
of 2.7 × 109 individual clones, representing the entire
obtainable repertoire of 12-mer peptide sequences, and
each clone expresses a random 12-amino-acid sequence.
Extensive sequencing of the naive library has revealed a
wide diversity of sequences with no obvious positional
biases. The E. coli host strain ER2738 (a robust F+ strain
with a rapid growth rate, New England Biolabs) was used
for M13 phage propagation.
Screening of phage display libraries
The phage libraries were screened by biopanning using
standard methods with a few modifications [20]. Briefly, a
96-well microtitre plate was coated with 100 μg/ml of C4
in 0.1 M NaHCO3 buffer (pH 8.6) and incubated over-
night at 4°C with gentle agitation in a humidified cham-
ber. The coating solution was poured off, and each well
was completely filled with blocking buffer (5 mg of
bovine serum albumin [BSA]/ml in 0.1 M NaHCO3 buffer
[pH 8.6]) and incubated for 1 h at 4°C. Protein-coated
wells were washed with TBST (Tris-buffered saline plus
0.1% Tween 20) at least six times before biopanning of
phage libraries. A Ph.D.-12 phage library with a titer of
1011 pfu was incubated in the wells (100 μl/well) for 1 h at
room temperature on a rocker. Nonbinding phage was
poured off, and the wells were washed 10 times with 300
μL/well TBST. The phages binding to the anti-PPV-VP1
were then eluted with 0.2 M glycine-HCl buffer (pH 2.2)
containing 1 mg BSA/ml. After elution, the acidic buffer
was neutralized with 1 M Tris-HCl (pH 9.1). The eluted
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amplified phage was purified by double precipitation with
1/6 volume of polyethylene glycol (PEG)-NaCl (20% [vol/
vol] PEG 8000, 2.5 M NaCl) and used in a second round
of biopanning. In the first, second, and third round of
biopanning, the Tween 20 concentration was increased
progressively from 0.1 to 0.3 to 0.5% to wash off nonspe-
cifically adhered phages. After three rounds of positive
selection, E. coli ER2738 cells were infected with the
eluted phage and grown on LB-agar plates coated with X-
Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside
at 0.04 m/v)/IPTG (0.05 m/v). Individual plaques were
picked and amplified, and single-stranded phage DNA
was isolated for sequencing.
ELISA
ELISA using phage supernatant and purified antibody
was used to evaluate the binding ability of individual
phage clones. Briefly, the eluted phages from the third
round of panning were transfected to E. coli and plated to
LB/IPTG/Xgal plates. Following overnight incubation at
37 °C, blue plaques were randomly selected and amplified
in E. coli in LB medium overnight at 37 °C. The phage
supernatants from these infected E. coli were then used in
the ELISA. Purified C4 mAb (100 μL/well in 0.1 M
NaHCO3 buffer (pH 8.6)) was added to a 96-well microti-
ter plate and blocked with BSA (5 mg/ml). The selected
peptide phage clones, amplified and concentrated by the
PEG-NaCl precipitation method, were added to each
coated well (1010 pfu/well) and incubated for 1 h at 37°C.
Unbound phages were removed by washing with TBST
(0.5% Tween 20), and bound phage were detected with
horseradish peroxidase-conjugated anti-M13 monoclonal
antibody (Amersham Pharmacia Biotech, Uppsala, Swe-
den) at 1:5 000 and with TMB (3,3',5,5'-tetramethyl benz-
idine) substrate (Sigma). The optical density (OD) value
of each well was read at 450 nm on an ELISA reader (Bio-
Rad, Model 550). If the phage clones obtained after
screening were true VP1 binders, then the ELISA signals
should be substantially higher with the clones added than
with the background.
Competitive ELISA
Positive phage clones identified in the ELISA test were
further explored for their specific binding to purified
antibodies of PPV by a competition-inhibition ELISA.
For each clone tested, PPV (1.0 μg/well) was mixed with
phage (1 × 109 pfu/well) and added to the wells of a 96-
well microtitre plate that had been previously coated with
purified C4 (1.0 μg/well) as described above. The bound
phage was detected as above using HRP/anti-M13 mono-
clonal antibody (1:5000). All tests were done in triplicate.
One positive clone was selected for more detailed testing.
This detailed testing involved a competitive ELISA, per-
formed as described above except that serial dilutions of
PPV were used.
Sequence analysis of selected phages
After three rounds of in vitro panning, 50 plaques were
randomly selected and their sequences analyzed with an
ABI Automatic DNA Analyzer (Shanghai Bioengineering
Ltd. Shanghai, China). The primer used for sequencing
was 5'-CCCTCATAGTTAGCGTAACG-3'(-96 gIII
sequencing primer, provided in the Ph.D.-12 Phage dis-
play peptide library kit, New England Biolabs). Homolo-
gous analysis and multiple sequence alignment were done
using DNAStar and Clustal W programs to determine the
relationships among the peptides.
Mouse immunization and serum analysis
Sixteen 8-week-old female BALB/c mice were housed in
the animal facility and allowed ad libitum access to feed
and water. At day 0, the mice were divided randomly into
four groups with four mice per group. Each mouse in
group 1 was inoculated intramuscularly with with one of
the 10 positive phage clones at a dose of 1010 pfu [21]. The
mice in group 2 were used as a negative control and were
inoculated with the primer phage library at the same
dose. The mice in group 3 were used as a positive control
and were inoculated with 100 μL of PPV (100 μg/mL,
buffered with PBS). The mice in group 4 were used as
another negative control and were inoculated with 100 μL
of PBS. All of the injections were mixed with the same
volume of adjuvant (SEPPIC Company). A booster inocu-
lation was carried out in the same manner for two times
at 2-week intervals. At day 35, all the mice were killed by
bleeding. The serum of each mouse was assayed by
ELISA.
Results
Identification of mAb by western-blot and 
immunofluorescent antibody test
PPV was used as the antigen to produce specific mAbs.
Fifteen hybridoma cell lines secreting antibodies against
the VP1, VP2, and VP3 proteins were isolated. The mAbs
were determined by western immunoblots (Fig 1a and Fig
1b). Two hybridoma lines were specific for protein VP1,
and others were specific for VP2 or VP3. All of them also
gave a good response in ELISA, with the titers of ascites
ranging from 1:2 560 to 1:20 480. The mAb C4, which
recognized VP1, was identified by the immunofluores-
cent antibody test (Fig 2), and it could produce high titer,
then it was selected for biopanning.
Peptide library screening
The B-cell epitopes of mAbs against the protein VP1 were
studied by the phage display method. The affinity-puri-
fied antibodies were immobilized on the ELISA plate, and
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ning cycles. Ten positive phage clones were identified,
and the ten selected phage clones produced by protein
VP1 showed significant increases in reactivity to their
antibodies (Table 1).
Homology analysis of exogenous sequences of selected 
phage clones
Ten positive phage clones highly reactive with antibodies
to protein VP1 were further sequenced, and the corre-
sponding exogenous sequence was given a sequential
name from P1 to P10. The phage-displayed peptide
sequences were aligned using DNAStar software to ana-
lyze the epitopes of the antibodies. The alignment analy-
sis revealed amino acid homology in that all 10 clones
contained a sequence of R-K-R (arginine-lysine-arginine).
Amino acid sequences were identical for P3 and P4, and
for P9 and P10. Clones P1 to P6 had a P residue on the
RKR-N-terminal (Fig 3).
Core identity and sequence analysis of the results
Amino acid sequence homology between 10 positive
clones and VP1 of PPV is shown in Fig 4. The results
show that R-K-R is a mimotope motif of VP1 (Fig. 3).
Sequencing showed that the 10 phage clones that reacted
to the PPV mAb included eight different 12-peptide
sequences, which all contained lysine and arginine as
conserved residues but different amino acids in other
positions. Except for clone P8, the other clones recognize
the core sequence arginine-lysine-arginine.
Mouse immunization and serum analysis
Anti-peptide sera colleted from mice immunized with the
phage clones from the VP1 group were tested with HI
and the competitive ELISA method to confirm the speci-
ficity of the polysera (inhibition by mAb). Each of the
peptides was recognized by the respective serum from
infected mice (Table 2). The BALB/c mice inoculated
with positive clones produced antibodies that were rec-
ognized by both HI and competitive ELISA.
Discussion
To our knowledge, this is the first report on the use of
phage display technology to screen epitopes or "mimo-
topes" of VP1 of PPV. VP1 and VP2 are different tran-
scription products from the same gene. Although there is
uncertainty about the exact length of VP1 because of the
presence of different possible splicing sites, it might con-
sist of up to 748 amino acid residues [22].
Identification of the VP1 epitope requires the prepara-
tion of an mAb. Such preparation includes selection and
purification of the immunogen and determination of
immunogenicity and immunogen dosage. A mAB C4 spe-
cific to VP1 of PPV was used as the target protein to
screen the phage displayed peptide library. After three
rounds of panning, phage clones capable of binding to the
mAB C4 were enriched, showing an increase in titre.
Although mAbs can be prepared with low-purity viral
antigen, antigen impurity will affect the screening of
mAbs and even influence the production of antibody.
Because the virions of PPV are small, normal ultracentrif-
Figure 1 Western-blot of mAbs with PPV. a. Western-blot analysis of 
the purified mAb with PPV-VP1, 82 KD; b. Western-blot analysis of the 
purified mAb with PPV-VP2, 64 KD.
Figure 2 The immunofluorescent antibody (IFA) test on ST cells. a. 
IFA test of purified C4 reacted with PPV on ST cells; b. IFA test of positive 
sera reacted with PPV on ST cells; c. Negative control.
Table 1: The results and yield rate of three rounds of biopanning of the phage display peptide libraries.
Round Input Output Yield (%)
1 1.5 × 1011 4 × 102 2.7 × 10-9
2 1.5 × 1011 4 × 104 2.7 × 10-7
3 1.5 × 1011 6 × 104 4 × 10-7
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tion are inadequate. In contrast, density gradient
centrifugation is a simple and inexpensive technique that
can effectively separate small proteins in different layers
of the centrifugation medium. In the present study, we
used cane sugar density gradient centrifugation to purify
the immunogen. We found that the cane sugar solution
should be used immediately after preparation because
stored solutions can give poor results. The volume of
viral solution added to the upper layer should not excel 3
ml; greater volumes can lead to gradient collapse. Antigen
immunogenicity directly influences the quality of the
mAb. Although artificially expressed protein has been
used as the immunogen to prepare mAb in many studies,
the structure of artificial protein can differ from that of
natural protein, and we therefore selected the whole virus
to inoculate the mice by intramuscularly. A preliminary
study in our laboratory indicated that the inoculation
dosage of 100 μg of viral solution per mouse, followed by
two booster inoculations, resulted in the production of
sufficient quantities of activated B cells that produced 15
high-affinity mAbs.
Indirect ELISA indicated that the 15 mAbs did not rec-
ognize other viruses (PCV2, PRV, and PRRSV). IFA
showed that the 15 prepared strains all detected PPV.
Western blot demonstrated that two of the strains specif-
ically recognized VP1 protein (which is 82 KD), that 12
strains recognized both VP2 and VP3 (which are 64 KD),
and that one strain was not imprinted. The latter strain
might recognize the PPV conformation epitope, but fur-
ther research is required to support that inference.
Because VP2 is produced by VP3 hydrolysis, both have
the same sequence region. We therefore conjecture that
the 12 strains recognize the common antigen epitope of
VP2 and VP3.
Phage random peptide display is a new technique for
studying the epitope of simulated antigens. Before the
current study, there were no reports on the use of phage
display technology to identify epitopes of PPV antigens.
Random phage peptide display was used to screen the
PPV-VP1 simulated antigen epitope, and bioinformation
analysis indicated that the β-turn and random coil of the
screened epitope region mainly lies on the protein sur-
face. We used DNAstar software analysis of the second-
ary structure of matured multi-peptide related to the
simulated antigen epitope sequence to determine that
arginine-lysine-argine probably form the antigen epitope.
The results indicate that the sequence arginine-lysine-
argine is the key component of the epitope of the simu-
lated PPV-VP1 antigen. Whether a simulated antigen
with this epitope can substitute for VP1 protein antigen
requires further immunogenicity studies with animals. To
verify whether the positive phage clones from the ran-
dom peptide phage library can induce the production of
specific antibodies, the phage clones were inoculated into
BALB/c mice, and the specific serum antibody titers in
the mice were determined. The results showed that
BALB/c mice inoculated with positive clones produce
antibodies that were detected by both HI and ELISA. The
mouse immunization trial therefore provides strong evi-
dence that the mimotope played a role in producing anti-
body against PPV. This further illustrates that the 12-bit
analog form does induce antibodies. The peptides will of
course be recognized by the corresponding sera from
infected mice, even they are not specific. In addition, to
confirm the importance of AKR motif, control peptides
containing no or mutated AKR motif need be synthesized
and used as antigen to test sera samples from infected
mice and naturally infected pigs.
Conclusion
In summary, the current study has provided new infor-
mation about the structure of VP1 in PPV, information
that will be useful for further research on gene structure
and function of VP1. The study also shows the potential
for the use of peptide mimotopes as alternatives that are
currently used for diagnosis of PPV infection and for PPV
vaccines.
Figure 3 Sequence comparison of the 10 positive phage clones.
Figure 4 Sequence comparison of the positive peptides and VP1-
PPV BQ strain.
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